Vote: Committee vote · Health
Senate HealthFeb 24, 2026Result: passed
Sponsor · State Senator, District 32 · Democratic
Senate bill · S893 (2025-26)
Relates to the use of antipsychotic medications in nursing homes; imposes limits as to time and documentation; requires informed consent under certain circumstances.
Not chosen yet
Out of committee and scheduled for a vote by the full chamber.
New York State Senate
Same as A1461, the matching bill in the Assembly.
Amends the Public Health Law.
Health · New York State Assembly
Also referred to Health · New York State Senate.
This bill requires an enhanced level of informed consent before psycho- tropic medication can be prescribed for patients in nursing homes.
Filed with the bill. Read it on nysenate.gov (opens in a new tab)
Senate HealthFeb 24, 2026Result: passed
Senate HealthMar 4, 2025Result: passed
Albert A. Stirpe, Angelo Santabarbara and 29 more on Agora
The sponsor's argument
Under section 2803-c(3) of the Public Health Law, patients residing in nursing homes have the right to be fully informed of their condition and any proposed treatment, to refuse treatment, and to be free from chemi- cal restraints unless such a prescription is consistent with certain requirements that limit duration and guide use necessitated by an emer- gency. Psychotropic medications are drugs that affect brain activities associated with mental processes and behavior including antipsychotics, antidepressants, antianxiety drugs and hypnotics. Spurred by published reports, the Assembly Committee on Health held a public hearing in February 2015 to examine the use of psychotropic drugs in nursing homes. Consensus emerged that in far too many instances, psychotropic drugs are used without a differential diagnosis of mental illness, in order to quiet and calm patients who may be simply upset or excitable. Given that activities and diversions have been proven to effectively reduce disruptions related to simple anxiety, dementia and emotional upset, it is not in many patients' interests to expose them to the dangerous side effects of psychotropic drugs which include cognitive decline and addiction. This bill would require that before such drugs are ordered for a patient in a nursing home, the patient or their lawful surrogate be fully informed of the nature and seriousness of their condition, the anticipated benefit from the medication, the dosage and duration of the prescription, the probability, nature and degree of side effects, the reasonable alternatives to the drug and why the health care professional prefers the drug in this instance, and that the patient has the right to refuse consent for the drug, or later to revoke their consent.
This is the sponsor's own case for the bill, quoted from their memorandum. It is not Agora's description of what the bill does.
Reported out of committee
REPORTED AND COMMITTED TO AGING
NY Senate
Ordered to Third Reading CAL.56
ORDERED TO THIRD READING CAL.56
NY Assembly
Referred to committee
REFERRED TO HEALTH
NY Senate
Advanced to Third Reading CAL.146
ADVANCED TO THIRD READING CAL.146
NY Assembly
Reported out of committee
REPORTED
NY Assembly
Amend and Recommit to Aging
AMEND AND RECOMMIT TO AGING
NY Senate
Reported out of committee
REPORTED REFERRED TO CODES
NY Assembly
Amend and Recommit to Health
AMEND AND RECOMMIT TO HEALTH
NY Assembly
Reported out of committee
REPORTED AND COMMITTED TO AGING
NY Senate
Referred to committee
REFERRED TO HEALTH
NY Assembly
Referred to committee
REFERRED TO HEALTH
NY Senate
The summary comes from NY Open Legislation, the New York State Senate's public record. For more, see How we handle summaries.
The list shows the cosponsors who are on Agora, A to Z. The official record may list more.
Parties are shown in the same neutral colors.
From NY Open Legislation, the NY Senate and Assembly, and official rosters. This record was last updated Oct 30, 2026. About our data